Novartis (NVS) Reports In-Line Q3 EPS of $1.21; Guides FY15 Sales Growth
Go back to Novartis (NVS) Reports In-Line Q3 EPS of $1.21; Guides FY15 Sales Growth| NOVARTIS AG (NYSE: NVS) | Delayed: 140.89 -2.39 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.28 | 52 Week High | $89.15 | |||
| Open | $142.77 | 52 Week Low | $69.84 | |||
| Day High | $142.79 | P/E | N/A | |||
| Day Low | $140.68 | EPS | $0.00 | |||
| Volume | 813,740 | |||||



